Alcon showcases new data at APACRS 2025, emphasizing advancements in IOL technology and surgical precision for improved ...

ALC's Q2 earnings top estimates but revenues fall short, sending shares down more than 10% as margins tightened and 2025 ...

We recently published 10 Stocks Crash as AI Glow Fades. Alcon Inc. (NYSE:ALC) is one of Wednesday’s worst performers. Shares of Alcon Inc. snapped a six-day winning streak on Wednesday, losing 10.07 ...

For almost four decades, Tom McDonald was a part of the team at Fort Worth-born Alcon, which continues to make innovative moves in the world of eyecare products. He recaps the company’s first five ...

Alcon (NYSE:ALC) stock continues to decline as J.P. Morgan downgrades the company following mixed Q2 2025 results and lowered sales guidance. Read more here.

H.C. Wainwright upgraded CoreWeave (CRWV) to Buy from Neutral with an $180 price target. The stock's valuation "has sunk deep enough," the analyst tells investors in a research note. Arete also ...

It was a warm summer day but Malorie Thorson was dressed for winter as Gerry Kulzer sculpted a likeness of her head from a ...

Kite Pharma is acquiring Interius BioTherapeutics for $350 million, adding in vivo CAR T technology that could simplify treatment and expand patient access.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 2025 Wells Fargo Healthcare Conference. Company management ...

Wrath of the Righteous and Warhammer 40,000: Rogue Trader — together with Alcon Interactive Group revealed a selection of new ...